VTv Historical Financial Ratios

VTVT Stock

USD 17.21 0.01 0.06%

VTv Therapeutics is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 68.57, Dividend Yield of 0.0, PTB Ratio of 6.86 or Days Sales Outstanding of 24.31 will help investors to properly organize and evaluate vTv Therapeutics financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

About VTv Financial Ratios Analysis

vTv TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate VTv Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on VTv financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across VTv Therapeutics history.

VTv Therapeutics Financial Ratios Chart

At this time, VTv Therapeutics' Current Ratio is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 2.60 in 2025, whereas Free Cash Flow Yield is likely to drop (0.33) in 2025.

Price To Sales Ratio Days Sales Outstanding Inventory Turnover Days Of Inventory On Hand

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing vTv Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on VTv Therapeutics sales, a figure that is much harder to manipulate than other vTv Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from VTv Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Current Ratio is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 2.60 in 2025, whereas Free Cash Flow Yield is likely to drop (0.33) in 2025.

	2022	2024	2025 (projected)
Payables Turnover	0.0374	3.84	7.57
Days Of Inventory On Hand	59.51	53.56	65.5

Payables Turnover Days Of Inventory On Hand

VTv Therapeutics fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.3	0.49	-0.3	-0.33	-0.57	-0.21	0.3	0.63	-0.57	-0.36	0.61	-0.39	-0.33	0.56	0.72	0.26	0.44	0.15	-0.29	0.44	-0.39	-0.44	-0.32	0.2	0.3
Ptb Ratio	0.3		-0.08	0.02	0.06	0.06	-0.04	1.0	0.12	0.06	0.06	-0.04	0.05	-0.41	0.26	-0.04	-0.05	-0.06	-0.25	0.05	-0.06	-0.62	0.0	-0.95	0.11	-0.17
Days Sales Outstanding	0.49	-0.08		0.09	-0.62	-0.34	0.0	-0.08	0.18	-0.34	-0.04	0.42	0.13	-0.16	0.79	0.32	0.27	0.43	0.19	0.2	0.43	-0.02	-0.29	0.05	0.4	0.02
Book Value Per Share	-0.3	0.02	0.09		-0.08	0.74	0.3	0.02	-0.63	0.74	0.04	-0.72	0.89	0.35	-0.1	-0.51	0.12	-0.13	-0.57	0.54	-0.13	0.32	0.33	0.1	0.57	-0.37
Free Cash Flow Yield	-0.33	0.06	-0.62	-0.08		0.42	0.04	0.06	0.04	0.42	0.05	-0.41	0.0	0.29	-0.64	-0.33	-0.46	-0.9	-0.27	-0.09	-0.9	0.33	0.18	-0.02	-0.64	-0.34
Operating Cash Flow Per Share	-0.57	0.06	-0.34	0.74	0.42		0.25	0.06	-0.57	1.0	-0.07	-0.95	0.85	0.46	-0.49	-0.9	-0.35	-0.54	-0.74	0.63	-0.55	0.41	0.38	0.08	0.13	-0.42
Capex To Depreciation	-0.21	-0.04	0.0	0.3	0.04	0.25		-0.04	-0.17	0.25	-0.2	-0.18	0.25	-0.06	0.07	-0.16	-0.05	0.02	0.1	-0.14	0.02	-0.07	0.13	0.05	0.08	0.07
Pb Ratio	0.3	1.0	-0.08	0.02	0.06	0.06	-0.04		0.12	0.06	0.06	-0.04	0.05	-0.41	0.26	-0.04	-0.05	-0.06	-0.25	0.05	-0.06	-0.62	0.0	-0.95	0.11	-0.17
Ev To Sales	0.63	0.12	0.18	-0.63	0.04	-0.57	-0.17	0.12		-0.57	-0.25	0.46	-0.65	-0.26	0.24	0.59	-0.44	0.16	0.3	-0.54	0.16	-0.26	-0.36	-0.18	-0.55	0.26
Free Cash Flow Per Share	-0.57	0.06	-0.34	0.74	0.42	1.0	0.25	0.06	-0.57		-0.07	-0.95	0.85	0.46	-0.49	-0.9	-0.35	-0.54	-0.74	0.63	-0.55	0.41	0.38	0.08	0.13	-0.42
Roic	-0.36	0.06	-0.04	0.04	0.05	-0.07	-0.2	0.06	-0.25	-0.07		0.01	0.05	0.0	0.08	-0.09	0.11	-0.12	0.24	0.2	-0.12	0.1	0.21	-0.14	-0.04	-0.34
Inventory Turnover	0.61	-0.04	0.42	-0.72	-0.41	-0.95	-0.18	-0.04	0.46	-0.95	0.01		-0.75	-0.48	0.59	0.83	0.46	0.5	0.75	-0.49	0.51	-0.44	-0.38	-0.1	-0.02	0.37
Net Income Per Share	-0.39	0.05	0.13	0.89	0.0	0.85	0.25	0.05	-0.65	0.85	0.05	-0.75		0.37	-0.04	-0.77	-0.06	-0.25	-0.61	0.83	-0.25	0.32	0.36	0.06	0.48	-0.47
Days Of Inventory On Hand	-0.33	-0.41	-0.16	0.35	0.29	0.46	-0.06	-0.41	-0.26	0.46	0.0	-0.48	0.37		-0.47	-0.37	-0.16	-0.29	-0.56	0.27	-0.29	0.66	0.18	0.42	0.04	-0.06
Payables Turnover	0.56	0.26	0.79	-0.1	-0.64	-0.49	0.07	0.26	0.24	-0.49	0.08	0.59	-0.04	-0.47		0.41	0.33	0.5	0.47	0.11	0.5	-0.56	-0.11	-0.38	0.34	-0.09
Capex To Revenue	0.72	-0.04	0.32	-0.51	-0.33	-0.9	-0.16	-0.04	0.59	-0.9	-0.09	0.83	-0.77	-0.37	0.41		0.42	0.49	0.59	-0.74	0.49	-0.34	-0.39	-0.07	-0.03	0.4
Cash Per Share	0.26	-0.05	0.27	0.12	-0.46	-0.35	-0.05	-0.05	-0.44	-0.35	0.11	0.46	-0.06	-0.16	0.33	0.42		0.39	0.24	-0.05	0.39	-0.14	-0.12	0.01	0.69	0.14
Pocfratio	0.44	-0.06	0.43	-0.13	-0.9	-0.54	0.02	-0.06	0.16	-0.54	-0.12	0.5	-0.25	-0.29	0.5	0.49	0.39		0.29	-0.17	1.0	-0.32	-0.39	0.04	0.53	0.66
Interest Coverage	0.15	-0.25	0.19	-0.57	-0.27	-0.74	0.1	-0.25	0.3	-0.74	0.24	0.75	-0.61	-0.56	0.47	0.59	0.24	0.29		-0.46	0.3	-0.43	0.05	0.04	-0.29	0.02
Capex To Operating Cash Flow	-0.29	0.05	0.2	0.54	-0.09	0.63	-0.14	0.05	-0.54	0.63	0.2	-0.49	0.83	0.27	0.11	-0.74	-0.05	-0.17	-0.46		-0.17	0.24	0.26	0.0	0.41	-0.45
Pfcf Ratio	0.44	-0.06	0.43	-0.13	-0.9	-0.55	0.02	-0.06	0.16	-0.55	-0.12	0.51	-0.25	-0.29	0.5	0.49	0.39	1.0	0.3	-0.17		-0.32	-0.39	0.04	0.53	0.66
Days Payables Outstanding	-0.39	-0.62	-0.02	0.32	0.33	0.41	-0.07	-0.62	-0.26	0.41	0.1	-0.44	0.32	0.66	-0.56	-0.34	-0.14	-0.32	-0.43	0.24	-0.32		-0.22	0.76	-0.01	0.09
Income Quality	-0.44	0.0	-0.29	0.33	0.18	0.38	0.13	0.0	-0.36	0.38	0.21	-0.38	0.36	0.18	-0.11	-0.39	-0.12	-0.39	0.05	0.26	-0.39	-0.22		-0.17	-0.14	-0.73
Roe	-0.32	-0.95	0.05	0.1	-0.02	0.08	0.05	-0.95	-0.18	0.08	-0.14	-0.1	0.06	0.42	-0.38	-0.07	0.01	0.04	0.04	0.0	0.04	0.76	-0.17		-0.03	0.28
Ev To Operating Cash Flow	0.2	0.11	0.4	0.57	-0.64	0.13	0.08	0.11	-0.55	0.13	-0.04	-0.02	0.48	0.04	0.34	-0.03	0.69	0.53	-0.29	0.41	0.53	-0.01	-0.14	-0.03		0.19
Pe Ratio	0.3	-0.17	0.02	-0.37	-0.34	-0.42	0.07	-0.17	0.26	-0.42	-0.34	0.37	-0.47	-0.06	-0.09	0.4	0.14	0.66	0.02	-0.45	0.66	0.09	-0.73	0.28	0.19

Click cells to compare fundamentals

VTv Therapeutics Account Relationship Matchups

VTv Therapeutics fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	13.67	15.56	25.23	78.37	90.12	68.57
Ptb Ratio	(1.09)	(6.4)	(4.74)	(0.97)	6.53	6.86
Days Sales Outstanding	8.99	5.19	2.2K	22.25	25.59	24.31
Book Value Per Share	(67.97)	(6.22)	(5.59)	(8.9)	2.48	2.6
Free Cash Flow Yield	(0.45)	(0.21)	(0.31)	(0.32)	(0.8)	(0.33)
Operating Cash Flow Per Share	(15.27)	(12.33)	(8.35)	(9.15)	(4.39)	(4.6)
Stock Based Compensation To Revenue	0.16	0.59	0.63	2.71	3.12	2.88
Pb Ratio	(1.09)	(6.4)	(4.74)	(0.97)	6.53	6.86
Ev To Sales	12.92	12.45	19.58	42.4	48.76	54.34
Free Cash Flow Per Share	(15.27)	(12.33)	(8.36)	(9.15)	(4.39)	(4.6)
Roic	(0.93)	(1.24)	(0.87)	(33.6)	(0.73)	(0.77)
Net Income Per Share	(7.49)	(11.32)	(13.06)	(9.71)	(3.2)	(3.36)
Payables Turnover	5.72	0.0474	0.0374	3.34	3.84	7.57
Sales General And Administrative To Revenue	1.13	3.08	6.05	13.42	15.44	11.88
Research And Ddevelopement To Revenue	1.72	3.33	6.12	11.35	13.06	12.4
Cash Per Share	5.19	8.63	6.32	4.56	6.37	6.05
Pocfratio	(4.87)	(3.23)	(3.18)	(1.26)	(3.15)	(3.31)
Interest Coverage	(17.13)	(1.8K)	(1.5K)	(2.0K)	(2.3K)	(2.1K)
Pfcf Ratio	(4.87)	(3.23)	(3.17)	(1.26)	(3.15)	(3.31)
Days Payables Outstanding	63.79	7.7K	9.8K	109.41	98.47	93.54
Income Quality	1.41	1.09	0.64	0.94	1.11	0.78
Ev To Operating Cash Flow	(2.47)	(4.6)	(2.58)	(0.79)	(1.7)	(1.79)
Pe Ratio	(9.93)	(3.52)	(2.03)	(1.18)	(4.32)	(4.53)
Return On Tangible Assets	(0.6)	(0.7)	(0.75)	(1.84)	(0.48)	(0.51)
Ev To Free Cash Flow	(2.46)	(4.6)	(2.58)	(0.79)	(1.7)	(1.79)
Net Debt To E B I T D A	0.4	0.71	0.46	0.35	1.62	1.71
Current Ratio	1.13	1.84	3.52	1.0	7.34	7.7
Tangible Book Value Per Share	(67.97)	(6.22)	(5.59)	(8.9)	2.48	2.6
Receivables Turnover	40.59	70.26	0.16	16.4	18.86	17.92
Shareholders Equity Per Share	(67.97)	(6.22)	(5.59)	(11.84)	2.11	2.22
Debt To Equity	(0.0114)	(0.0957)	(0.0667)	(0.0214)	0.0139	0.0145
Graham Net Net	(75.07)	(13.8)	(11.73)	(9.58)	2.22	2.33

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

VTv Historical Financial Ratios

About VTv Financial Ratios Analysis

VTv Therapeutics Financial Ratios Chart

Price To Sales Ratio

Inventory Turnover

VTv Therapeutics fundamentals Correlations

VTv Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

VTv Therapeutics fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for VTv Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Net Income Per Share	+ 0.89	Book Value Per Share
Net Income Per Share	+ 0.85	Operating Cash Flow Per Share
Net Income Per Share	+ 0.85	Free Cash Flow Per Share

Inventory Turnover	- 0.95	Free Cash Flow Per Share
Roe	- 0.95	Pb Ratio
Inventory Turnover	- 0.95	Operating Cash Flow Per Share
Roe	- 0.95	Ptb Ratio
Capex To Revenue	- 0.9	Free Cash Flow Per Share
Capex To Revenue	- 0.9	Operating Cash Flow Per Share